MEDIPHARM ANDERLECHT

Evere ·KBO/BCE: BE 0803.351.426

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	31-08-2025	31 d late	2025-00456966
31-12-2023	31-07-2024	31-08-2024	31 d late	2024-00455048

Metric	This company	Sector median	Position in the sector
Solvency	-5.3%	20.4%	better than 24% of 6697 sector peers
Net result	€-31k	€4k	better than 8% of 6677 sector peers
Equity	€-14k	€16k	better than 16% of 6711 sector peers
Gross operating margin	€132k	€24k	better than 87% of 6656 sector peers
Staff costs	€152k	€33k	higher than 91% of 3034 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€262k
Fixed assets	21/28	€52k
Intangible fixed assets	21	€52k
Current assets	29/58	€210k
Stocks & contracts in progress	3	€73k
Amounts receivable within one year	40/41	€42k
Cash & bank	54/58	€59k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€262k
Equity	10/15	€-14k
Contributions / capital	10/11	€3k
Accumulated profits (losses)	14	€-17k
Amounts payable	17/49	€276k
Amounts payable within one year	42/48	€276k
Trade debts payable within one year	44	€125k
Income statement
Gross operating margin	9900	€132k
Operating result	9901	€-29k
Financial income	75	€4
Financial charges	65	€2k
Result before taxes	9903	€-31k
Net result for the period	9904	€-31k
Result to be appropriated	9905	€-31k

Summary